Citation Impact
Citing Papers
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
2010 Standout
Hyperplasia and Carcinomas in Pten-Deficient Mice and Reduced PTEN Protein in Human Bladder Cancer Patients
2006 StandoutNobel
Host Response to Implanted Porcine-Derived Biologic Materials in a Primate Model of Abdominal Wall Repair
2008
Design, Synthesis, and Evaluation of Radiolabeled Integrin α v β 3 Receptor Antagonists for Tumor Imaging and Radiotherapy
2003
Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine
2013
The multifaceted regulation and functions of PKM2 in tumor progression
2014
Tubular kidney injury molecule‐1 (KIM‐1) in human renal disease
2007 Standout
Emerging roles of PKM2 in cell metabolism and cancer progression
2012 StandoutNobel
Engineering precision nanoparticles for drug delivery
2020 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers
2005
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
2008 StandoutNature
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
2012 Standout
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Rapamycin is an effective inhibitor of human renal cancer metastasis11See Editorial by Sukhatme and Strom, p. 1160.
2003
Histologic Grading of Noninvasive Papillary Urothelial Tumors : Validation of the 1998 WHO/ISUP System by Immunophenotyping and Follow-up
2004
Phase I and pharmacokinetic study of etaracizumab (Abegrin™), a humanized monoclonal antibody against αvβ3 integrin receptor, in patients with advanced solid tumors
2007
The metabolic syndrome
2010 Standout
Cancer Cell Metabolism: Warburg and Beyond
2008 Standout
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
2010 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Screening for Bladder Cancer: Rationale, Limitations, Whom to Target, and Perspectives
2013
Otto Warburg's contributions to current concepts of cancer metabolism
2011 Standout
DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells
2005 Standout
The von Hippel-Lindau Gene, Kidney Cancer, and Oxygen Sensing
2003 StandoutNobel
The immune contexture in cancer prognosis and treatment
2017 Standout
Tumor Cell Metabolism: Cancer's Achilles' Heel
2008 Standout
Renal and Extrarenal Effects of Gum Arabic (Acacia Senegal) - What Can be Learned from Animal Experiments?
2013 Standout
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
An overview of tissue and whole organ decellularization processes
2011 Standout
Pyruvate kinase type M2 and its role in tumor growth and spreading
2005
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Expression of Integrin αVβ3 in Pancreatic Carcinoma: Relation to MMP-2 Activation and Lymph Node Metastasis
2002
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
2010 Standout
The metabolic syndrome
2005 Standout
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Regulation of cancer cell metabolism
2011 Standout
Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer
2014
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
2016 Standout
Diagnosis of urothelial carcinoma from urine
2009
Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology
2017 Standout
Bladder cancer
2016 Standout
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
2005 Standout
KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi’s sarcoma
2015 StandoutNobel
Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex
2001
Downregulation of Angiogenin Transcript Levels and Inhibition of Colonic Carcinoma by Gum Arabic (Acacia senegal)
2010
Oxidative Stress in Cancer
2020 Standout
Urine Markers for Bladder Cancer Surveillance: A Systematic Review
2005
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
2017 Standout
Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells
2010
Renal cell carcinoma: Current status and emerging therapies
2007
Bladder biomechanics and the use of scaffolds for regenerative medicine in the urinary bladder
2018
Regulation of glycolysis by Raf protein serine/threonine kinases
2002
Uromodulin Biology and Pathophysiology – An Update
2010
Regulation of Metabolism by Hypoxia-Inducible Factor 1
2011 StandoutNobel
Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients
2005 Standout
Human Kidney Injury Molecule-1 Is a Tissue and Urinary Tumor Marker of Renal Cell Carcinoma
2005
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
The primary cilium: a signalling centre during vertebrate development
2010 Standout
Cancer Statistics, 2002
2002 Standout
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
2011 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
2011 Standout
New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c
2002
Tumor Markers in the Diagnosis of Primary Bladder Cancer. A Systematic Review
2003
Incisional ventral hernias: Review of the literature and recommendations regarding the grading and technique of repair
2010 Standout
Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells
2011 StandoutNobel
A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity
2002
Direct targeting of αvβ3 integrin on tumor cells with a monoclonal antibody, Abegrin™
2006
Making sense of cilia in disease: The human ciliopathies
2009
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
Computer-Aided Prostate Cancer Detection Using Ultrasound RF Time Series: In Vivo Feasibility Study
2015
Avidity and Cell Uptake of Integrin-Targeting Polypeptide Micelles is Strongly Shape-Dependent
2019
Clinical Implications of Circulating Angiogenic Factors in Cancer Patients
2001
Specific features of glycogen metabolism in the liver
1998
Standardization of sample collection, isolation and analysis methods in extracellular vesicle research
2013 Standout
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
2014 Standout
Cell Adhesion Proteins As Tumor Suppressors
2002
Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification
2001
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Systematic Reviews of Diagnostic Test Accuracy
2008
Works of Gerhard Feil being referenced
Investigations of Urothelial Cells Seeded on Commercially Available Small Intestine Submucosa
2006
Comparison of Cytology and Nuclear Matrix Protein 22 for the Detection and Follow-Up of Bladder Cancer
2001
Excretion of Tamm-Horsfall Protein in Patients with Uric Acid Stones
1999
The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines
2011
Liver glycogen synthase deficiency: A rarely diagnosed entity
1996
Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
1999
Polysyndaktylie, verk�rzte Gliedma�en und Genitalfehlbildungen: Kennzeichen eines selbst�ndigen Syndroms?
1971
Liver glycogen synthase deficiency: a rarely diagnosed entity
1996
Control of hepatic parameters in renal cell carcinoma (RCC) by interleukin-6 (IL-6)?
1999
Combinations of urine-based tumour markers in bladder cancer surveillance
2009
[Polysyndactyly, short limbs, and genital malformations--a new syndrome?].
1971
Renal cell carcinoma: relevance of angiogenetic factors.
1999
Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer.
2001
Renal cell carcinoma: immunohistological investigation of expression of the integrin alpha v beta 3.
1999
Heterogeneity in prostate cancer: prostate specific antigen (PSA) and DNA cytophotometry.
2005
Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder.
2003